Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Marbofloxacin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 494Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Aurore Life Sciences
    India
    		 AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN CEP 2021-449 - Rev 00 Marbofloxacin for veterinary use 2023-12-19 Valid Chemical 2233
    28/10/2024 NGL Fine Chem Limited
    India
    		 NGL FINE-CHEM LIMITED Mumbai IN CEP 2022-218 - Rev 00 Marbofloxacin for veterinary use 2024-09-13 Valid Chemical 2233